Soluble IL-2a and ovarian cancer
1994
Questions on Soluble IL-2 Receptor in Ovarian Cancer
Commentary
Author Information
Author(s): D.P.J. Barton
Primary Institution: Temple University School of Medicine
Conclusion
The commentary raises concerns about the understanding and evaluation of the soluble interleukin-2 receptor in ovarian cancer.
Supporting Evidence
- The author points out inaccuracies in the previous report regarding the soluble interleukin-2 receptor.
- The author mentions their own previous studies on the levels of this receptor in ovarian cancer.
Takeaway
This letter discusses some mistakes in a previous report about a protein related to ovarian cancer and highlights the importance of understanding how it works.
Want to read the original?
Access the complete publication on the publisher's website